Dr Pryor Brenner, MD | |
1060 W Perimeter Rd, Jb Andrews, MD 20762-6602 | |
(240) 612-1660 | |
Not Available |
Full Name | Dr Pryor Brenner |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 21 Years |
Location | 1060 W Perimeter Rd, Jb Andrews, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134242142 | NPI | - | NPPES |
200108044 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 01059894A (Indiana) | Secondary |
207Y00000X | Otolaryngology | 2022006412 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Sibley Memorial Hospital | Washington, DC | Hospital |
Cox Medical Centers | Springfield, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lester E Cox Medical Centers | 8628092897 | 219 |
Chevy Chase Ent Associates, Llc | 0446286314 | 6 |
News Archive
Mercator Therapeutics, the first biopharmaceutical company to systematically use in vivo phage display technology to develop novel cancer drugs, and X-BODY BioSciences, a developer of monoclonal antibody therapeutics, today announced a multi-target research collaboration.
Atherosclerosis is a disease in which arteries narrow due to plaques. That narrowing can lead to heart attacks and strokes - both of which are leading causes of death in the U.S.
The Center for Public Integrity reports on a trend in which many physicians and other medical professionals are billing Medicare for complicated and costly care. Some say this pattern signals an increase in medical billing abuse while others maintain it reflects seniors' need for more complex care.
Two complementary guidelines on the diagnosis and treatment of allergic rhinitis are published in the August issue of the Allergy journal.
› Verified 4 days ago
Entity Name | Lester E Cox Medical Centers |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760405864 PECOS PAC ID: 8628092897 Enrollment ID: O20060116000342 |
News Archive
Mercator Therapeutics, the first biopharmaceutical company to systematically use in vivo phage display technology to develop novel cancer drugs, and X-BODY BioSciences, a developer of monoclonal antibody therapeutics, today announced a multi-target research collaboration.
Atherosclerosis is a disease in which arteries narrow due to plaques. That narrowing can lead to heart attacks and strokes - both of which are leading causes of death in the U.S.
The Center for Public Integrity reports on a trend in which many physicians and other medical professionals are billing Medicare for complicated and costly care. Some say this pattern signals an increase in medical billing abuse while others maintain it reflects seniors' need for more complex care.
Two complementary guidelines on the diagnosis and treatment of allergic rhinitis are published in the August issue of the Allergy journal.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Pryor Brenner, MD 1060 W Perimeter Rd, Jb Andrews, MD 20762-6602 Ph: (240) 612-1660 | Dr Pryor Brenner, MD 1060 W Perimeter Rd, Jb Andrews, MD 20762-6602 Ph: (240) 612-1660 |
News Archive
Mercator Therapeutics, the first biopharmaceutical company to systematically use in vivo phage display technology to develop novel cancer drugs, and X-BODY BioSciences, a developer of monoclonal antibody therapeutics, today announced a multi-target research collaboration.
Atherosclerosis is a disease in which arteries narrow due to plaques. That narrowing can lead to heart attacks and strokes - both of which are leading causes of death in the U.S.
The Center for Public Integrity reports on a trend in which many physicians and other medical professionals are billing Medicare for complicated and costly care. Some say this pattern signals an increase in medical billing abuse while others maintain it reflects seniors' need for more complex care.
Two complementary guidelines on the diagnosis and treatment of allergic rhinitis are published in the August issue of the Allergy journal.
› Verified 4 days ago